Resources

Selected
  • 华夏幸福 散户数量 -28.38 含义
Type of publications
Regions
Diseases
5046 results found
2022 ∙ Marra, A. R. Kobayashi, T. Suzuki, H. Alsuhaibani, M. Schweizer, M. L. Diekema, D. J. Tofaneto, B. M. Bariani, L. M. Auler, M. A. Salinas, J. L. Edmond, M. B. Pinho, J. R. R. Rizzo, L. V.
The long-term effectiveness of coronavirus disease 2019 (COVID-19) vaccines: A systematic literature review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Nguyen, H. S. Vo, N. P. Chen, S. Y. Tam, K. W.
The optimal strategy for pertussis vaccination: a systematic review and meta-analysis of randomized control trials and real-world data
Newborn Pregnant women Pertussis Efficacy/effectiveness Safety Economic aspects
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Halemani, K. Dhiraaj, S. Latha, T. Mishra, P. Issac, A.
The prevalence of COVID vaccine acceptance among pregnant women: A systematic review and meta-analysis
All age groups Pregnant women COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Nindrea, Ricvan Dana Djanas, Dovy Warsiti, Darma, Ika Yulia Hendriyani, Heni Sari, Nissa Prima
The risk factors and pregnant women's willingness toward the SARS-CoV-2 vaccination in various countries: A systematic review and meta-analysis
Pregnant women COVID-19 Acceptance Coverage
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Sapienza, A. Falcone, R.
The Role of Trust in COVID-19 Vaccine Acceptance: Considerations from a Systematic Review
All age groups COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Ou, L. Youngstedt, S. D.
The Role of Vaccination Interventions to Promote HPV Vaccine Uptake Rates in a College-Aged Population: a Systematic Review
Adults Human papillomavirus (HPV) Coverage Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2022 ∙ Zou, Y. Huang, D. Jiang, Q. Guo, Y. Chen, C.
The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis
All age groups COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Petrelli, F. Luciani, A. Borgonovo, K. Ghilardi, M. Parati, M. C. Petrò, D. Lonati, V. Pesenti, A. Cabiddu, M.
Third Dose of SARS-CoV-2 Vaccine: A Systematic Review of 30 Published Studies
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Mani, Avinash Ojha, Vineeta
Thromboembolism after Covid-19 vaccination: a systematic review of such events in 286 patients
Adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kim, Ah Young Woo, Wongi Yon, Dong Keon Lee, Seung Won Yang, Jae Won Kim, Ji Hong Park, Seoyeon Koyanagi, Ai Kim, Min Seo Lee, Sungsoo Shin, Jae Il Smith, Lee
Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...